The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
US firms reported mixed Q2 results on August 6, highlighted by Symbotic's 22% year-over-year revenue growth to $721 million. While Dorman Products achieved record quarterly sales and earnings, the company lowered its revenue growth outlook for the full year. Additionally, Trupanion authorized a $100 million share repurchase program following improved enrollment performance.